Integra Lifesciences (IART) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

IART Integra Lifesciences

Watchlist

21.800
+0.090+0.41%

Close Dec 20 16:00 ET

21.800
0.0000.00%

Post 16:54 ET

1.68BMarket Cap-242.22P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Here's Why Integra LifeSciences Holdings Corporation (IART) Fell in Q3
Yahoo FinanceDec 19 10:34 ET
Integra Lifesciences Implements New Severance Program for Executives
TipRanksDec 17 16:47 ET
Integra LifeSciences Holdings Insiders Added US$2.50m Of Stock To Their Holdings
Simply Wall StDec 4 08:07 ET
Morgan Stanley Initiates Integra Lifesciences(IART.US) With Sell Rating, Announces Target Price $20
Moomoo NewsDec 2 08:31 ET · Ratings
Integra LifeSciences Assumed With an Underweight at Morgan Stanley
TipRanksDec 2 07:25 ET
Reasons to Retain IART Stock in Your Portfolio for Now
Zacks Nov 25 07:00 ET

Comments

Money Mover

Jul 1 10:35

Going to miss guidance/earnings

$Integra Lifesciences (IART.US)$ its a buy at $24

Money Mover

Jun 27 14:20

$Integra Lifesciences (IART.US)$ Integra LifeSciences Price Target Cut to $25.00/Share From $45.00 by Wells Fargo

Moomoo AI

Feb 11 08:35

EPS growth doesn't align with share price, indicating it may not reflect business performance or growth expectations may have been high. Integra LifeSciences Holdings' performance led to a 3% annual loss for shareholders over five years. Investors should note 3 warning signs.

While Shareholders of Integra LifeSciences Holdings (NASDAQ:IART) Are in the Red Over the Last Three Years, Underlying Earnings Have Actually Grown

Moomoo AI

Jan 29 04:30

Insider transactions suggest a positive outlook for Integra LifeSciences Holdings, with insiders net buying the stock. The level of insider ownership indicates a reasonable degree of alignment with shareholder interests.

Several Insiders Invested In Integra LifeSciences Holdings Flagging Positive News

Moomoo AI

Jan 15 05:36

Integra LifeSciences Holdings trades at a low price, suggesting a buying opportunity. Higher cash flow is expected, potentially boosting share valuation. The positive outlook seems not fully factored into the share price, indicating it's not too late to buy IART.

At US$42.94, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?

Heat List

Overall

No Data

Investment Theme

Brain-Computer Interface

Intraday+0.39%